Discontinuation report ZOFRAN
Report ID | 123894 |
Drug Identification Number | 02213745 |
Brand name | ZOFRAN |
Common or Proper name | ZOFRAN INJ 4MG AMPS 2ML 5'S |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 2ML X 5'S |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-03-31 |
Actual discontinuation date | 2021-04-19 |
Remaining supply date | 2023-02-28 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2021-05-05 | French | Compare |
v9 | 2021-05-05 | English | Compare |
v8 | 2021-03-09 | French | Compare |
v7 | 2021-03-09 | English | Compare |
v6 | 2020-11-06 | French | Compare |
v5 | 2020-11-06 | English | Compare |
v4 | 2020-11-06 | French | Compare |
v3 | 2020-11-06 | English | Compare |
v2 | 2020-09-09 | French | Compare |
v1 | 2020-09-09 | English | Compare |
Showing 1 to 10 of 10